<SEC-DOCUMENT>0001144204-18-006635-index.html : 20180208
<SEC-HEADER>0001144204-18-006635.hdr.sgml : 20180208
<ACCEPTANCE-DATETIME>20180208162556
ACCESSION NUMBER:		0001144204-18-006635
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20180208
DATE AS OF CHANGE:		20180208
GROUP MEMBERS:		CELGENE ALPINE INVESTMENT CO. III, LLC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89674
		FILM NUMBER:		18586091

	BUSINESS ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CELGENE CORP /DE/
		CENTRAL INDEX KEY:			0000816284
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				222711928
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		86 MORRIS AVENUE
		CITY:			SUMMIT
		STATE:			NJ
		ZIP:			07901
		BUSINESS PHONE:		(908)673-9000

	MAIL ADDRESS:	
		STREET 1:		86 MORRIS AVENUE
		CITY:			SUMMIT
		STATE:			NJ
		ZIP:			07901
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>tv485248_sc13da.htm
<DESCRIPTION>SC 13D/A
<TEXT>
Document 1 - file: tv485248_sc13da.htm

</DOCUMENT>
</SEC-DOCUMENT>